1563MO CoVigi phase IV multicentric trial evaluating COVID-19 vaccination adverse events and immune response dynamics in cancer patients: First results on antibody and cellular imm...

por Obermannova, R., Demlova, R., Selingerova, I., Doubek, M., Okrouhlicova, D., Mlnarikova, M., Pilatova, K., Nevrlka, J., Lejdarova, H., Weinbergerova, B., Cermakova, Z., Valik, D., Mayer, J., Kiss, I., Zdrazilova-Dubska, L.
Publicado 2021